ReechPharma, LLC

ReechPharma is a formulation research and development company offering customized drug product development solutions to address physicochemical, biopharmaceutical, intellectual property, and regulatory challenges in compliance with FDA and global regulations.

Core Services

Preclinical Formulations:

• API characterization (solubility, stability, thermal and morphology analysis)
• Preformulation studies (compatibility, chemical and physical characterization, stability evaluation)
• Design and development of preclinical formulations for efficacy testing, animal PK/DMPK studies, and GLP toxicity assessments
• Dosage form development (immediate release, modified/extended release, nano-particle solutions, semisolids)

Clinical Formulations:

• Prototype formulations for first-in-human studies
• Phase-appropriate dosage form design
• GLP/GMP supplies for animal studies and Phase I manufacturing
• Pediatric and geriatric formulations

Analytical Services:

• Drug release profile and dissolution testing
• Stability storage and testing
• Analytical testing and release of API and dosage forms

Infrastructure & Expertise

The company operates cleanrooms and maintains equipment including Nanomill, hot melt extruder, HPLCs, UPLC, dissolution/disintegration testers, UV spectrometer, stability chambers, and scanning electron microscope. The team combines 75+ years of hands-on product development experience with a hybrid approach utilizing classical and modern methodologies to accelerate development timelines and reduce costs.